▶ 調査レポート

抗肥満治療薬の世界市場予測 2023年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Anti-Obesity Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

GlobalInfoResearchが調査・発行した産業分析レポートです。抗肥満治療薬の世界市場予測 2023年:メーカー別、地域別、種類・用途別 / Global Anti-Obesity Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023 / C-GIR010246資料のイメージです。• レポートコード:C-GIR010246
• 出版社/出版日:GlobalInfoResearch / 2018年8月
• レポート形態:英文、PDF、128ページ
• 納品方法:Eメール
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Single User¥382,800 (USD3,480)▷ お問い合わせ
  Multi User¥574,200 (USD5,220)▷ お問い合わせ
  Corporate User¥765,600 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、抗肥満治療薬の世界市場について調査・分析し、抗肥満治療薬の世界市場概観、メーカー動向、メーカー別抗肥満治療薬シェア、市場規模推移、市場規模予測、抗肥満治療薬種類別分析(中枢性抗肥満薬、末梢作用性抗肥満薬)、抗肥満治療薬用途別分析(病院の使用、クリニックの使用、家庭、その他)、主要地域分析(北米、欧州、アジア)、主要国分析データなどを含め、以下の構成でお届け致します。
・抗肥満治療薬の市場概観
・抗肥満治療薬のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・抗肥満治療薬のメーカー別販売動向、市場シェア、市場集中度、競争動向
・抗肥満治療薬の世界市場規模
・抗肥満治療薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・抗肥満治療薬のアメリカ市場規模推移
・抗肥満治療薬のカナダ市場規模推移
・抗肥満治療薬のメキシコ市場規模推移
・抗肥満治療薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・抗肥満治療薬のドイツ市場規模推移
・抗肥満治療薬のイギリス市場規模推移
・抗肥満治療薬のロシア市場規模推移
・抗肥満治療薬のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・抗肥満治療薬の日本市場規模推移
・抗肥満治療薬の中国市場規模推移
・抗肥満治療薬の韓国市場規模推移
・抗肥満治療薬のインド市場規模推移
・抗肥満治療薬の東南アジア市場規模推移
・抗肥満治療薬の南米・中東・アフリカ市場分析
・抗肥満治療薬の種類別分析/市場規模推移(中枢性抗肥満薬、末梢作用性抗肥満薬)
・抗肥満治療薬の用途別分析/市場規模推移(病院の使用、クリニックの使用、家庭、その他)
・抗肥満治療薬の市場予測(地域別予測、種類別予測、用途別予測)
・抗肥満治療薬の販売チャネル・代理店・貿易業者・ディーラー分析

Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.

Scope of the Report:

This report focuses on the Anti-Obesity Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Geographically, North America captures the largest market share on account of increasing obese population. As per the historical trends, more than one-third of the U.S. population is obese. However, Asia Pacific is anticipated to grow at the fastest rate due to increasing demand for the drugs and awareness about the risk associated with obesity. According to WHO, 13.0% of the population were obese in 2014. In developing countries the rate of childhood obesity is increasing and has been 30.0% higher than that of developed countries.

The worldwide market for Anti-Obesity Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Bristol-Myers Squibb

Eisai Company

FlaxoSithKline plc.

Novo Nordisk

Alizyme

BoehringerIngelheim GmbH

Pfizer

Takeda Pharmaceutical

Rhythm Pharmaceuticals

Shionogi USA

Vivus

Zafgen

Norgine Pharmaceuticals Ltd.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Centrally Acting Anti-obesity Drugs

Peripherally Acting Anti-obesity Drugs

Market Segment by Applications, can be divided into

Hospital Use

Clinic Use

Household

Other

There are 15 Chapters to deeply display the global Anti-Obesity Therapeutics market.

Chapter 1, to describe Anti-Obesity Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Anti-Obesity Therapeutics, with sales, revenue, and price of Anti-Obesity Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Obesity Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Anti-Obesity Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Anti-Obesity Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

レポート目次

Table of Contents

1 Market Overview

1.1 Anti-Obesity Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Centrally Acting Anti-obesity Drugs

1.2.2 Peripherally Acting Anti-obesity Drugs

1.3 Market Analysis by Applications

1.3.1 Hospital Use

1.3.2 Clinic Use

1.3.3 Household

1.3.4 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Bristol-Myers Squibb

2.1.1 Business Overview

2.1.2 Anti-Obesity Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Eisai Company

2.2.1 Business Overview

2.2.2 Anti-Obesity Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Eisai Company Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 FlaxoSithKline plc.

2.3.1 Business Overview

2.3.2 Anti-Obesity Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novo Nordisk

2.4.1 Business Overview

2.4.2 Anti-Obesity Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novo Nordisk Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Alizyme

2.5.1 Business Overview

2.5.2 Anti-Obesity Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Alizyme Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 BoehringerIngelheim GmbH

2.6.1 Business Overview

2.6.2 Anti-Obesity Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Anti-Obesity Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Takeda Pharmaceutical

2.8.1 Business Overview

2.8.2 Anti-Obesity Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Rhythm Pharmaceuticals

2.9.1 Business Overview

2.9.2 Anti-Obesity Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Shionogi USA

2.10.1 Business Overview

2.10.2 Anti-Obesity Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Shionogi USA Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Vivus

2.11.1 Business Overview

2.11.2 Anti-Obesity Therapeutics Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Vivus Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Zafgen

2.12.1 Business Overview

2.12.2 Anti-Obesity Therapeutics Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Zafgen Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Norgine Pharmaceuticals Ltd.

2.13.1 Business Overview

2.13.2 Anti-Obesity Therapeutics Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Anti-Obesity Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Anti-Obesity Therapeutics Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Anti-Obesity Therapeutics Manufacturer Market Share in 2017

3.3.2 Top 6 Anti-Obesity Therapeutics Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Anti-Obesity Therapeutics Market Analysis by Regions

4.1 Global Anti-Obesity Therapeutics Sales, Revenue and Market Share by Regions

4.1.1 Global Anti-Obesity Therapeutics Sales and Market Share by Regions (2013-2018)

4.1.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Regions (2013-2018)

4.2 North America Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

4.3 Europe Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

4.5 South America Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

5 North America Anti-Obesity Therapeutics by Countries

5.1 North America Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries

5.1.1 North America Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)

5.1.2 North America Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)

5.2 United States Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

5.3 Canada Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

5.4 Mexico Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

6 Europe Anti-Obesity Therapeutics by Countries

6.1 Europe Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries

6.1.1 Europe Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)

6.2 Germany Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

6.3 UK Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

6.4 France Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

6.5 Russia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

6.6 Italy Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

7 Asia-Pacific Anti-Obesity Therapeutics by Countries

7.1 Asia-Pacific Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)

7.2 China Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

7.3 Japan Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

7.4 Korea Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

7.5 India Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

8 South America Anti-Obesity Therapeutics by Countries

8.1 South America Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries

8.1.1 South America Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)

8.1.2 South America Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

8.3 Argentina Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

8.4 Colombia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

9 Middle East and Africa Anti-Obesity Therapeutics by Countries

9.1 Middle East and Africa Anti-Obesity Therapeutics Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Anti-Obesity Therapeutics Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Anti-Obesity Therapeutics Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

9.3 UAE Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

9.4 Egypt Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

9.5 Nigeria Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

9.6 South Africa Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

10 Global Anti-Obesity Therapeutics Market Segment by Type

10.1 Global Anti-Obesity Therapeutics Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Anti-Obesity Therapeutics Sales and Market Share by Type (2013-2018)

10.1.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Centrally Acting Anti-obesity Drugs Sales Growth and Price

10.2.1 Global Centrally Acting Anti-obesity Drugs Sales Growth (2013-2018)

10.2.2 Global Centrally Acting Anti-obesity Drugs Price (2013-2018)

10.3 Peripherally Acting Anti-obesity Drugs Sales Growth and Price

10.3.1 Global Peripherally Acting Anti-obesity Drugs Sales Growth (2013-2018)

10.3.2 Global Peripherally Acting Anti-obesity Drugs Price (2013-2018)

11 Global Anti-Obesity Therapeutics Market Segment by Application

11.1 Global Anti-Obesity Therapeutics Sales Market Share by Application (2013-2018)

11.2 Hospital Use Sales Growth (2013-2018)

11.3 Clinic Use Sales Growth (2013-2018)

11.4 Household Sales Growth (2013-2018)

11.5 Other Sales Growth (2013-2018)

12 Anti-Obesity Therapeutics Market Forecast (2018-2023)

12.1 Global Anti-Obesity Therapeutics Sales, Revenue and Growth Rate (2018-2023)

12.2 Anti-Obesity Therapeutics Market Forecast by Regions (2018-2023)

12.2.1 North America Anti-Obesity Therapeutics Market Forecast (2018-2023)

12.2.2 Europe Anti-Obesity Therapeutics Market Forecast (2018-2023)

12.2.3 Asia-Pacific Anti-Obesity Therapeutics Market Forecast (2018-2023)

12.2.4 South America Anti-Obesity Therapeutics Market Forecast (2018-2023)

12.2.5 Middle East and Africa Anti-Obesity Therapeutics Market Forecast (2018-2023)

12.3 Anti-Obesity Therapeutics Market Forecast by Type (2018-2023)

12.3.1 Global Anti-Obesity Therapeutics Sales Forecast by Type (2018-2023)

12.3.2 Global Anti-Obesity Therapeutics Market Share Forecast by Type (2018-2023)

12.4 Anti-Obesity Therapeutics Market Forecast by Application (2018-2023)

12.4.1 Global Anti-Obesity Therapeutics Sales Forecast by Application (2018-2023)

12.4.2 Global Anti-Obesity Therapeutics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures



Figure Anti-Obesity Therapeutics Picture

Table Product Specifications of Anti-Obesity Therapeutics

Figure Global Sales Market Share of Anti-Obesity Therapeutics by Types in 2017

Table Anti-Obesity Therapeutics Types for Major Manufacturers

Figure Centrally Acting Anti-obesity Drugs Picture

Figure Peripherally Acting Anti-obesity Drugs Picture

Figure Anti-Obesity Therapeutics Sales Market Share by Applications in 2017

Figure Hospital Use Picture

Figure Clinic Use Picture

Figure Household Picture

Figure Other Picture

Figure United States Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure France Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure UK Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure China Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure India Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Anti-Obesity Therapeutics Revenue (Value) and Growth Rate (2013-2023)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors

Table Bristol-Myers Squibb Anti-Obesity Therapeutics Type and Applications

Table Bristol-Myers Squibb Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eisai Company Basic Information, Manufacturing Base and Competitors

Table Eisai Company Anti-Obesity Therapeutics Type and Applications

Table Eisai Company Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table FlaxoSithKline plc. Basic Information, Manufacturing Base and Competitors

Table FlaxoSithKline plc. Anti-Obesity Therapeutics Type and Applications

Table FlaxoSithKline plc. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novo Nordisk Basic Information, Manufacturing Base and Competitors

Table Novo Nordisk Anti-Obesity Therapeutics Type and Applications

Table Novo Nordisk Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Alizyme Basic Information, Manufacturing Base and Competitors

Table Alizyme Anti-Obesity Therapeutics Type and Applications

Table Alizyme Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table BoehringerIngelheim GmbH Basic Information, Manufacturing Base and Competitors

Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Type and Applications

Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Anti-Obesity Therapeutics Type and Applications

Table Pfizer Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Takeda Pharmaceutical Anti-Obesity Therapeutics Type and Applications

Table Takeda Pharmaceutical Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Rhythm Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Type and Applications

Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Shionogi USA Basic Information, Manufacturing Base and Competitors

Table Shionogi USA Anti-Obesity Therapeutics Type and Applications

Table Shionogi USA Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Vivus Basic Information, Manufacturing Base and Competitors

Table Vivus Anti-Obesity Therapeutics Type and Applications

Table Vivus Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Zafgen Basic Information, Manufacturing Base and Competitors

Table Zafgen Anti-Obesity Therapeutics Type and Applications

Table Zafgen Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Norgine Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors

Table Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Type and Applications

Table Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Anti-Obesity Therapeutics Sales by Manufacturer (2016-2017)

Figure Global Anti-Obesity Therapeutics Sales Market Share by Manufacturer in 2016

Figure Global Anti-Obesity Therapeutics Sales Market Share by Manufacturer in 2017

Table Global Anti-Obesity Therapeutics Revenue by Manufacturer (2016-2017)

Figure Global Anti-Obesity Therapeutics Revenue Market Share by Manufacturer in 2016

Figure Global Anti-Obesity Therapeutics Revenue Market Share by Manufacturer in 2017

Figure Top 3 Anti-Obesity Therapeutics Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Anti-Obesity Therapeutics Manufacturer (Revenue) Market Share in 2017

Figure Global Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Global Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)

Table Global Anti-Obesity Therapeutics Sales by Regions (2013-2018)

Table Global Anti-Obesity Therapeutics Sales Market Share by Regions (2013-2018)

Table Global Anti-Obesity Therapeutics Revenue by Regions (2013-2018)

Figure Global Anti-Obesity Therapeutics Revenue Market Share by Regions in 2013

Figure Global Anti-Obesity Therapeutics Revenue Market Share by Regions in 2017

Figure North America Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Europe Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure South America Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure North America Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)

Table North America Anti-Obesity Therapeutics Sales by Countries (2013-2018)

Table North America Anti-Obesity Therapeutics Sales Market Share by Countries (2013-2018)

Figure North America Anti-Obesity Therapeutics Sales Market Share by Countries in 2013

Figure North America Anti-Obesity Therapeutics Sales Market Share by Countries in 2017

Table North America Anti-Obesity Therapeutics Revenue by Countries (2013-2018)

Table North America Anti-Obesity Therapeutics Revenue Market Share by Countries (2013-2018)

Figure North America Anti-Obesity Therapeutics Revenue Market Share by Countries in 2013

Figure North America Anti-Obesity Therapeutics Revenue Market Share by Countries in 2017

Figure United States Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Canada Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Mexico Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Europe Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)

Table Europe Anti-Obesity Therapeutics Sales by Countries (2013-2018)

Table Europe Anti-Obesity Therapeutics Sales Market Share by Countries (2013-2018)

Table Europe Anti-Obesity Therapeutics Revenue by Countries (2013-2018)

Figure Europe Anti-Obesity Therapeutics Revenue Market Share by Countries in 2016

Figure Europe Anti-Obesity Therapeutics Revenue Market Share by Countries in 2017

Figure Germany Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure UK Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure France Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Russia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Italy Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Anti-Obesity Therapeutics Sales by Countries (2013-2018)

Table Asia-Pacific Anti-Obesity Therapeutics Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Anti-Obesity Therapeutics Sales Market Share by Countries 2017

Table Asia-Pacific Anti-Obesity Therapeutics Revenue by Countries (2013-2018)

Figure Asia-Pacific Anti-Obesity Therapeutics Revenue Market Share by Countries 2017

Figure China Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Japan Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Korea Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure India Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Southeast Asia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure South America Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)

Table South America Anti-Obesity Therapeutics Sales by Countries (2013-2018)

Table South America Anti-Obesity Therapeutics Sales Market Share by Countries (2013-2018)

Figure South America Anti-Obesity Therapeutics Sales Market Share by Countries in 2017

Table South America Anti-Obesity Therapeutics Revenue by Countries (2013-2018)

Table South America Anti-Obesity Therapeutics Revenue Market Share by Countries (2013-2018)

Figure South America Anti-Obesity Therapeutics Revenue Market Share by Countries in 2017

Figure Brazil Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Argentina Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Colombia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Anti-Obesity Therapeutics Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Anti-Obesity Therapeutics Sales by Countries (2013-2018)

Table Middle East and Africa Anti-Obesity Therapeutics Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Anti-Obesity Therapeutics Sales Market Share by Countries in 2017

Table Middle East and Africa Anti-Obesity Therapeutics Revenue by Countries (2013-2018)

Table Middle East and Africa Anti-Obesity Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Anti-Obesity Therapeutics Revenue Market Share by Countries in 2013

Figure Middle East and Africa Anti-Obesity Therapeutics Revenue Market Share by Countries in 2017

Figure Saudi Arabia Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure UAE Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Egypt Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure Nigeria Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Figure South Africa Anti-Obesity Therapeutics Sales and Growth Rate (2013-2018)

Table Global Anti-Obesity Therapeutics Sales by Type (2013-2018)

Table Global Anti-Obesity Therapeutics Sales Share by Type (2013-2018)

Table Global Anti-Obesity Therapeutics Revenue by Type (2013-2018)

Table Global Anti-Obesity Therapeutics Revenue Share by Type (2013-2018)

Figure Global Centrally Acting Anti-obesity Drugs Sales Growth (2013-2018)

Figure Global Centrally Acting Anti-obesity Drugs Price (2013-2018)

Figure Global Peripherally Acting Anti-obesity Drugs Sales Growth (2013-2018)

Figure Global Peripherally Acting Anti-obesity Drugs Price (2013-2018)

Table Global Anti-Obesity Therapeutics Sales by Application (2013-2018)

Table Global Anti-Obesity Therapeutics Sales Share by Application (2013-2018)

Figure Global Clinic Use Sales Growth (2013-2018)

Figure Global Household Sales Growth (2013-2018)

Figure Global Other Sales Growth (2013-2018)

Figure Global Anti-Obesity Therapeutics Sales, Revenue and Growth Rate (2018-2023)

Table Global Anti-Obesity Therapeutics Sales Forecast by Regions (2018-2023)

Table Global Anti-Obesity Therapeutics Market Share Forecast by Regions (2018-2023)

Figure North America Sales Anti-Obesity Therapeutics Market Forecast (2018-2023)

Figure Europe Sales Anti-Obesity Therapeutics Market Forecast (2018-2023)

Figure Asia-Pacific Sales Anti-Obesity Therapeutics Market Forecast (2018-2023)

Figure South America Sales Anti-Obesity Therapeutics Market Forecast (2018-2023)

Figure Middle East and Africa Sales Anti-Obesity Therapeutics Market Forecast (2018-2023)

Table Global Anti-Obesity Therapeutics Sales Forecast by Type (2018-2023)

Table Global Anti-Obesity Therapeutics Market Share Forecast by Type (2018-2023)

Table Global Anti-Obesity Therapeutics Sales Forecast by Application (2018-2023)

Table Global Anti-Obesity Therapeutics Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List